Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults.

Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults.

A previously presented physiologically-based pharmacokinetic model for immediate release (IR) methylphenidate (MPH) was extended to characterize the pharmacokinetic behaviors of oral extended release (ER) MPH formulations in adults for the first time. Information on the anatomy and physiology of the...

Bibliografski detalji
Glavni autori:	Xiaoxia Yang, John Duan, Jeffrey Fisher
Format:	Članak
Jezik:	English
Izdano:	Public Library of Science (PLoS) 2016-01-01
Serija:	PLoS ONE
Online pristup:	http://europepmc.org/articles/PMC5056674?pdf=render

Slični predmeti

Use of physiologically‐based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended‐release nifedipine
od: Ming‐Liang Tan, i dr.
Izdano: (2024-02-01)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
od: Xiaoxia eYang, i dr.
Izdano: (2015-01-01)

Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidate.
od: Jurjen van der Schans, i dr.
Izdano: (2015-01-01)

Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis
od: Armagan Aral, i dr.
Izdano: (2022-08-01)

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
od: John S. Markowitz, i dr.
Izdano: (2022-11-01)

Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models
od: Louis Lin, i dr.
Izdano: (2017-09-01)

A convolution‐based in vitro‐in vivo correlation model for methylphenidate hydrochloride delayed‐release and extended‐release capsule
od: Pawan Kumar Gupta, i dr.
Izdano: (2024-01-01)

Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers
od: Farr SJ, i dr.
Izdano: (2015-01-01)

Food Effects on Oral Drug Absorption: Application of Physiologically-Based Pharmacokinetic Modeling as a Predictive Tool
od: Lisa Cheng, i dr.
Izdano: (2020-07-01)

Physiologically based pharmacokinetic modeling of long‐acting extended‐release naltrexone in pregnant women with opioid use disorder
od: Babajide Shenkoya, i dr.
Izdano: (2024-11-01)

Full-profile pharmacokinetics, anticancer activity and toxicity of an extended release trivalent PEGylated irinotecan prodrug
od: Shiwen Song, i dr.
Izdano: (2023-08-01)

Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG
od: Alfredo Durand-Rivera, i dr.
Izdano: (2015-01-01)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
od: Rafał Bieś, i dr.
Izdano: (2023-09-01)

Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics
od: Luiza de Oliveira Macedo, i dr.
Izdano: (2024-08-01)

Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection
od: Sandor-Adrian Klis, i dr.
Izdano: (2024-08-01)

Predicting absorption and pharmacokinetic profile of carbamazepine from controlled-release tablet formulation in humans using rabbit model
od: Homšek Irena, i dr.
Izdano: (2011-01-01)

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
od: Jan K Buitelaar, i dr.
Izdano: (2009-08-01)

Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film
od: Fang Chen, i dr.
Izdano: (2020-02-01)

Methylphenidate enhances implicit learning in healthy adults
od: Klinge, C, i dr.
Izdano: (2017)

Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions
od: Saima Subhani, i dr.
Izdano: (2023-02-01)

Evaluation and comparison of pharmacokinetic profiles and safety of two extended-release buprenorphine formulations in common marmosets (Callithrix jacchus)
od: Niora J. Fabian, i dr.
Izdano: (2023-07-01)

Application of Physiologically Based Pharmacokinetic Models in Chemical Risk Assessment
od: Moiz Mumtaz, i dr.
Izdano: (2012-01-01)

Clofazimine pharmacokinetics in HIV‐infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics
od: Cindy X. Zhang, i dr.
Izdano: (2024-03-01)

Adult and pediatric physiologically‐based biopharmaceutics modeling to explain lamotrigine immediate release absorption process
od: Edilainy Rizzieri Caleffi‐Marchesini, i dr.
Izdano: (2024-02-01)

Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats
od: Yoo-Kyung Song, i dr.
Izdano: (2021-03-01)

Effect of Oral Methylphenidate on the Experimental Epileptiform Activity in Male Rats
od: Yousef Panahi, i dr.
Izdano: (2020-01-01)

Methylphenidate Abuse
od: J Gordon Millichap
Izdano: (1994-11-01)

Methylphenidate and Seizures
od: J Gordon Millichap
Izdano: (1989-10-01)

A Physiologically‐Based Pharmacokinetic Model for the Prediction of “Half‐Life Extension” and “Catch and Release” Monoclonal Antibody Pharmacokinetics
od: Hannah M. Jones, i dr.
Izdano: (2020-09-01)

Absorption profile fitting tests on data release.
od: Rogers, Alan E.E.
Izdano: (2024)

Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study
od: Youran Xu, i dr.
Izdano: (2023-01-01)

Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets
od: Franke RM, i dr.
Izdano: (2015-08-01)

Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets
od: Swiss Medical Weekly
Izdano: (2011-09-01)

Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder
od: Ali Karayağmurlu, i dr.
Izdano: (2022-09-01)

ADDH And Methylphenidate Response
od: J Gordon Millichap
Izdano: (1994-07-01)

Trial of Methylphenidate and Thioridazine
od: J Gordon Millichap
Izdano: (1991-09-01)

Methylphenidate Dosing Schedules
od: J Gordon Millichap
Izdano: (1996-11-01)

ADHD, Creativity, and Methylphenidate
od: J Gordon Millichap
Izdano: (1993-04-01)

Methylphenidate and Sleep Patterns
od: J Gordon Millichap
Izdano: (1994-01-01)

Epilepsy, ADHD, and Methylphenidate
od: J Gordon Millichap
Izdano: (1997-05-01)